MSB Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP - 9th Feb 2023, 9:39am

annb0t

annb0t

Top 20
MSB Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP
Price Sensitive: N
Date: 9th Feb 2023, 9:39am

>>> Read announcement: Google: MSB Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
MSB Ann: Mesoblast Type A Meeting with FDA - 21st Sep 2023, 10:09am
Replies
0
Views
113
annb0t
annb0t
annb0t
MSB Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection - 22nd Mar 2023, 11:08am
Replies
0
Views
124
annb0t
annb0t
annb0t
MSB Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L - 8th Mar 2023, 10:35am
Replies
0
Views
216
annb0t
annb0t
annb0t
MSB Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD - 1st Feb 2023, 9:30am
Replies
0
Views
142
annb0t
annb0t
annb0t
MSB Ann: Submits New Information to FDA IND File for SR-aGVHD - 3rd Oct 2022, 9:49am
Replies
0
Views
212
annb0t
annb0t
Top Bottom